Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice-Reference-Cited by-同舟云学术

Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice

Published:2014-12-01 Issue:12 Volume:9 Page:e113533
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dubois Martine,Le Joncour Vadim,Tonon Marie-Christine,Anouar Youssef,Proust François,Morin Fabrice,Gandolfo Pierrick,Joly Florence,Hilber Pascal,Castel Hélène

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference77 articles.

1. Cognitive dysfunction and cancer: which consequences in terms of disease management?;F Joly;Psychooncology,2011

2. Targeting mammalian target of rapamycin (mTOR) for health and diseases;CK Tsang;Drug Discov Today,2007

3. Reversible posterior leukoencephalopathy syndrome and bevacizumab;P Glusker;N Engl J Med,2006

4. Reversible posterior leukoencephalopathy syndrome induced by sunitinib;G Martin;J Clin Oncol,2007

5. Fatigue in renal cell carcinoma: the hidden burden of current targeted therapies;JM Larkin;Oncologist,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia;HAEMATOLOGICA;2022

2. Quand le développement médical d’un complément alimentaire ouvre des opportunités inattendues… sérendipité ? Du bénéfice de Qiseng® dans la fatigue post-cancer à son intérêt potentiel dans les troubles cognitifs post-COVID;Hegel;2021-06-11

3. Inhibition of mTOR signaling by genetic removal of p70 S6 kinase 1 increases anxiety-like behavior in mice;Translational Psychiatry;2021-03-15

4. Inhibition of mTOR signaling by genetic removal of p70 S6 Kinase 1 leads to anxiety-like disorders;2020-03-25